PARVOVIRUS PET-GUARD is the first vaccine manufactured and registered in Mexico for the prevention of canine hemorrhagic gastroenteritis asso ciated with parvovirus that immunizes against field parvoviral serotypes CPV2, CPV2a and CPB2b. PARVOVIRUS PET-GUARD is produced with the L-85 strain isolated in Mex ico, typified, attenuated and cloned due to its immunogenic features by James Baker at the Cornell University Institute in New York, United States, to provide this product with maximum stability. The virus is cultured in homologous cell lines of canine origin, acknowledged and certified, which grants high specificity and secures the absence of contaminating viruses. PARVOVIRUS PET-GUARD has an elevated antigenicity since it is man ufactured with a reduced number of passes in tissue cultures and has adequate viral titers attached to the NOM. PARVOVIRUS PET-GUARD rep licates in the host in a benign form bestowing solid and long-lasting humoral and cell-mediated immunity on it.
Subcutaneous or intramuscular administration.
Keep at a temperature between 4°C and 8°C. Shake before use. The vac cine must be applied only on healthy animals. Avoid heating or freezing. Handle aseptically. New and sterile syringes must be used. As any other biological product, it may trigger anaphylactic reactions. Keep in a dry and cool place. Keep away from sunlight. Keep out of the reach of children.
Each ml contains:
Canine Parvovirus, L-85 strain, live and modified in cell cultures, with a titer of 1 x 103 per ml.